Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination …,

The global randomized, open-label, multi-center Phase 2 PROFECTA-II clinical trial of afuresertib is the world’s first registration-directed clinical study of …, The global randomized, open-label, multi-center Phase 2 PROFECTA-II clinical trial of afuresertib is the world’s first registration-directed clinical study of …, Read More

Scroll to Top